IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer

Clinical trial NCT04854590 · COMPLETED

Trial details

NCT number: NCT04854590
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Small Cell

Start date: 2021-04-22
Primary completion: 2023-07-25
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.